Watch our presentation: “The Future of HDR Brachytherapy: locally recurrent prostate cancer”
6 May, 2021
12:45-13:45 CET
|
|
Dr. Wojcieszek’s presentation, “The Future of HDR Brachytherapy: locally recurrent prostate cancer,” will discuss how:
- HDR Brachytherapy is excellent to treat local prostate cancer recurrence
- Radiobiological features of HDR allow sterilizing relapsing cells inside the prostate
- The outcome is similar to other methods; however, GI toxicity is the lowest
- There is a great need to coordinate prospective research on salvage HDR worldwide
Other speakers at our Lunch Symposium will share their clinical experiences with Geneva, one applicator for the majority of cervical cancer cases. They will also share how they are creating awareness about brachytherapy with a patient portal.
Register for WCB |